News Record: EnableUC students engineer 3D-printed hand
The student organization made a specialized prosthetic for a man who lost his hand in an accident
EnableUC, a student organization at the University of Cincinnati, serves as a bridge between engineering and medicine for people with upper limb differences, said Sumedha Kappagantula, a biomedical engineering student and EnableUC internal vice president. The News Record, the UC student news organization, featured EnableUC in a recent article.
Members of EnableUC provide low-cost custom prosthetics and they have designed and created 35 assistive devices and 17 prosthetics. One recent project tasked the group with building a 3D-printed prosthetic hand for a man who lost his hand in an accident with machine equipment. The prosthetic required special modifications to accommodate the man’s work as a machinist, Andrew Dilley told The News Record. Dilley is EnableUC’s president and a biomedical engineering student at UC.
EnableUC recently built prosthetic arms with elbow functionality for a Bolivian teenager who lost both of his hands in a dynamite explosion.
Featured image at top: Bolivian teenager Clisver Barrientos Mendez uses prosthetics designed and built by the UC student group EnableUC. Photo/Provided
Related Stories
Withrow Pathway to Lindner program challenges, motivates students
December 3, 2024
Three graduates of Cincinnati Public Schools’ Withrow University High School of Business credit the partnership between the school and the Carl H. Lindner College of Business for their enrollment in the college.
B-O-L-O-G-N-A: The staying power of Oscar Mayer’s jingle
December 3, 2024
Few commercials have the staying power of the Oscar Mayer bologna jingle, which still has a place in American culture 50 years after its debut. James Kellaris, a professor of marketing at the University of Cincinnati, explained to NPR’s All Things Considered why the advertisement was so successful.
Cancer Center study if vaccines can prevent lung cancer...
December 3, 2024
WLWT highlighted a University of Cincinnati Cancer Center clinical trial exploring whether personalized mRNA vaccines are effective at reducing lung cancer recurrence.